142 related articles for article (PubMed ID: 16248785)
1. Design of Inhibitors for S100B.
Markowitz J; Mackerell AD; Carrier F; Charpentier TH; Weber DJ
Curr Top Med Chem; 2005; 5(12):1093-108. PubMed ID: 16248785
[TBL] [Abstract][Full Text] [Related]
2. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins.
Markowitz J; MacKerell AD; Weber DJ
Mini Rev Med Chem; 2007 Jun; 7(6):609-16. PubMed ID: 17584159
[TBL] [Abstract][Full Text] [Related]
3. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
5. The evolution of S100B inhibitors for the treatment of malignant melanoma.
Hartman KG; McKnight LE; Liriano MA; Weber DJ
Future Med Chem; 2013 Jan; 5(1):97-109. PubMed ID: 23256816
[TBL] [Abstract][Full Text] [Related]
6. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
[TBL] [Abstract][Full Text] [Related]
7. In vivo screening of S100B inhibitors for melanoma therapy.
Zimmer DB; Lapidus RG; Weber DJ
Methods Mol Biol; 2013; 963():303-17. PubMed ID: 23296618
[TBL] [Abstract][Full Text] [Related]
8. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53.
Delphin C; Ronjat M; Deloulme JC; Garin G; Debussche L; Higashimoto Y; Sakaguchi K; Baudier J
J Biol Chem; 1999 Apr; 274(15):10539-44. PubMed ID: 10187847
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.
Lin J; Yang Q; Yan Z; Markowitz J; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2004 Aug; 279(32):34071-7. PubMed ID: 15178678
[TBL] [Abstract][Full Text] [Related]
11. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulation of S100B protein to explore ligand blockage of the interaction with p53 protein.
Zhou Z; Li Y
J Comput Aided Mol Des; 2009 Oct; 23(10):705-14. PubMed ID: 19597941
[TBL] [Abstract][Full Text] [Related]
13. Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.
Agamennone M; Cesari L; Lalli D; Turlizzi E; Del Conte R; Turano P; Mangani S; Padova A
ChemMedChem; 2010 Mar; 5(3):428-35. PubMed ID: 20077460
[TBL] [Abstract][Full Text] [Related]
14. Theoretical study on binding of S100B protein.
Gieldon A; Mori M; Del Conte R
J Mol Model; 2007 Nov; 13(11):1123-31. PubMed ID: 17713798
[TBL] [Abstract][Full Text] [Related]
15. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
[TBL] [Abstract][Full Text] [Related]
16. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Rustandi RR; Baldisseri DM; Weber DJ
Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
[TBL] [Abstract][Full Text] [Related]
17. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis.
Wilder PT; Baldisseri DM; Udan R; Vallely KM; Weber DJ
Biochemistry; 2003 Nov; 42(46):13410-21. PubMed ID: 14621986
[TBL] [Abstract][Full Text] [Related]
18. Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS).
Young BD; Yu W; RodrÃguez DJV; Varney KM; MacKerell AD; Weber DJ
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450915
[TBL] [Abstract][Full Text] [Related]
19. Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells.
Yoshimura C; Miyafusa T; Tsumoto K
Bioorg Med Chem; 2013 Mar; 21(5):1109-15. PubMed ID: 23375094
[TBL] [Abstract][Full Text] [Related]
20. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.
Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4735-40. PubMed ID: 15781852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
